$WOOF

May Holly sold $638K of WOOF

May Holly (Chief Human Resources Officer) sold 250,000 shares of Petco Health & Wellness Company, Inc. (WOOF) at $2.55 ($0.64M total) across 2 trades over 2026-07-07 to 2026-07-08.

Original reporting
SEC EDGAR · May Holly
Published Jul 9, 2026, 8:42 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 9, 2026, 8:48 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$WOOF
Neutral
high confidence
Mentioned
$WOOF
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$WOOFNeutralLow
01

Why it matters

The only new information is the insider sale details (shares, price, dates, and post-transaction holdings).

02

Market read

Traders may note the insider selling as a sentiment datapoint, but there is no new fundamental information.

03

What to watch

No 10b5-1 plan is stated, but the filing does not disclose intent, tax planning, or whether future sales are planned, limiting interpretability.

Relevance 5/10Novelty 5/10Timing: new Form 4 filed July 9, covering sales July 7-8

Background

The article is a SEC Form 4 insider transaction disclosure for Petco Health & Wellness Company, Inc.

Company-level read

Ticker impact

$WOOFNeutralHigh confidence
Context

Petco HR officer May Holly sold 250,000 shares in open-market transactions at $2.55/share, per a newly filed Form 4.

Expected impact

Likely limited near-term impact; any effect is more sentiment-driven than fundamental.

Evidence & confidence

This is a routine Form 4 insider sale with no 10b5-1 plan and no accompanying company news, so it is typically low signal for valuation.

Market effects

Minimal; this is company-specific insider activity with no sector-wide regulatory or earnings signal.

None indicated.

None indicated.

Counterpoint

The sale could be for diversification or personal liquidity needs, especially since the transactions were small relative to the company’s broader market context.

Key entities

  • Petco Health & Wellness Company, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • May Holly

    Chief Human Resources Officer who sold shares in open-market transactions.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WOOFHigh

WOOF Jumps As Petco EPS Beat Triggers Bullish Re‑Rating

Petco Health and Wellness (WOOF) shares rose 7.14% after Q2 earnings beat estimates ($0.13 EPS vs $0.05-$0.07 expected) and revenue of ~$1.5B. Analysts raised targets to $3.25-$4.00, citing turnaround progress, but note high debt and thin margins. Stock is consolidating near $2.70, with support at $2.50.

$WOOFHigh

WOOF Jumps As Petco Earnings Beat Sparks Turnaround Hopes

Petco Health and Wellness (WOOF) stock rose 7.14% after Q2 earnings beat expectations, with EPS at $0.13 vs. estimates of $0.05-$0.07. Revenue was flat YoY at ~$1.5B but slightly ahead of estimates. The company improved profitability and prepaid ~$170M of debt, addressing balance sheet concerns. Analysts see potential upside to $3.50 if margin expansion continues.

$WOOFHigh

Petco (WOOF) Shares Skyrocket, What You Need To Know

Petco (WOOF) shares rose 7.2% after Q2 earnings beat estimates, with net sales of $1.49B and EPS of $0.13. Comparable store sales grew 0.6%, and the company made a $75M debt prepayment. Management reaffirmed its FY2026 outlook. The stock is volatile, down 5.4% YTD and 31.1% from its 52-week high.

$WOOFHighAI 8/10

Why is Petco Health and Wellness stock surging today?

Petco Health and Wellness (WOOF) stock rose 11.8% in pre-market trading after reporting fiscal Q2 2026 earnings that exceeded expectations. EPS was $0.113 vs. $0.071 estimate, adjusted EBITDA was $122.2M vs. $110-$112M guidance, and revenue was $1.49B. The company also prepaid $75M in debt, reducing net debt by 15% YoY. Management reaffirmed full-year 2026 outlook, citing progress in its strategic plan and positive comparable sales growth.